News
Imaging3?, Inc. (OTCBB: IMGG), developer of a breakthrough medical
imaging device that produces 3D medical diagnostic images of virtually
any part of the human body in real-time, announced that at 2:00pm PDT
(5:00pm EDT), Monday, May 21st, 2012, the company's CEO, Mr. Dean
Janes, will be hosting a conference call. To join the conference call,
please call 1-888-205-6786 and enter passcode 161478 followed by the
pound sign (#). You will be connected to the conference call in a
listen only mode, and then lines will be opened for questions
following the presentation.
The purpose of the call is to update Shareholders and other interested
parties of the current developments with the company.
A limited number of lines will be available for this conference call.
The lines will open up 5 minutes prior to the start of the call.
A recording of the conference call will be made available on the
company's website as soon as it is available. Imaging3 will notify
shareholders and others who subscribe to the company newsletter.
Anyone who would like to be added to this list is encouraged to
sign-up for the e-mail based newsletter on the company's website using
the following link --
http://www.imaging3.com/newsletters_signup.html(http://www.imaging3.com/newsletters_signup.html).
About Imaging3Imaging3, Inc., founded in 1993, is a leading provider
of advanced technology medical imaging devices. The Company has
developed a breakthrough medical imaging device that produces 3D
medical diagnostic images of virtually any part of the human body in
real-time. Because these 3D images are instantly constructed in
real-time, they can be used for any current or new medical procedures
in which multiple frames of reference are required to perform medical
procedures on or in the human body. Visit the company's website at
http://www.imaging3.com(http://www.imaging3.com/) for more information
Safe Harbor Statement Matters discussed in this press release contain
forward-looking statements within the meaning of the Private
Securities Litigation Reform Act of 1995. When used in this press
release, the words "anticipate," "believe," "estimate," "may,"
"intend," "expect" and similar expressions identify such
forward-looking statements. Actual results, performance or
achievements could differ materially from those contemplated,
expressed or implied by the forward-looking statements contained
herein. These forward-looking statements are based largely on the
expectations of the Company and are subject to a number of risks and
uncertainties. These include, but are not limited to, risks and
uncertainties associated with: the impact of economic, competitive and
other factors affecting the Company and its operations, markets,
product, and distributor performance, technological obsolescence,
competition from other medical instrument(s) and imaging companies,
lack of capital, unexpected costs, failure or delay of FDA approval,
absence of revenue, the impact on the national and local economies
resulting from an economic recession or terrorist actions, and U.S.
actions subsequently; unavailability of financing for the Company or
its customers, product malfunction and potential product liability
claims, and other factors detailed in reports filed by the Company.
